SCHEMBL4032742

SCHEMBL4032742

COC(=O)c1ccc2cc(C(O)(c3c[nH]cn3)C(C)C)ccc2c1

nearest known ligand 0.65

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 16/20 0.65
CYP17A1 P05093 16/20 0.65
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5752821 0.89 CYP17A1 (0.62) CYP3A4CYP17A1CYP2C9CYP2C19
SCHEMBL4030233 0.88 CYP17A1 (0.53) CYP3A4CYP17A1CYP2C9CYP2C19
SCHEMBL4025132 0.88 CYP17A1 (0.66) CYP3A4CYP17A1CYP2C9CYP2C19
SCHEMBL4029239 0.88 CYP17A1 (0.66) CYP3A4CYP17A1CYP2C9CYP2C19
SCHEMBL7537438 0.87 CYP17A1 (0.65) CYP3A4CYP17A1CYP2C9CYP2C19
SCHEMBL4025340 0.87 CYP17A1 (0.65) CYP3A4CYP17A1CYP2C9CYP2C19
SCHEMBL7537443 0.87 CYP17A1 (0.65) CYP3A4CYP17A1CYP2C9CYP2C19
SCHEMBL4025212 0.87 CYP17A1 (0.65) CYP3A4CYP17A1CYP2C9CYP2C19
SCHEMBL5754667 0.86 CYP17A1 (0.51) CYP3A4CYP17A1CYP2C9CYP2C19
SCHEMBL4025856 0.86 CYP17A1 (0.64) CYP3A4CYP17A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222174-B1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA PHARMACEUTICAL (JP) 2009-05-27 EP disclosed
US-6800778-B1 OPTICALLY ACTIVE CYCLIC PHOSPHORUS COMPOUND USED AS REAGENT FOR OPTICAL RESOLUTION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-10-05 US disclosed
US-6649643-B1 Antitumor, anticarcinogenic, and antimetastasis agents; benign prostatic hyperplasia, alopecia, endometriosis, uterine myoma, hirsutism, virilism, precocious puberty, mastopathy, and polycystic overay syndrome treatment TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-11-18 US disclosed
EP-1227085-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE DERIVATIVE AND OPTICAL RESOLVER THEREFOR Takeda Chemical Industries, Ltd. (JP) 2002-07-31 EP disclosed
EP-1222174-A1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE Takeda Chemical Industries, Ltd. (JP) 2002-07-17 EP disclosed
WO-2001030762-A1 IMIDAZOL-4-YLMETHANOLS USE AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-03 WO disclosed